Leprosy as a Cause of Distal Symmetric Polyneuropathy--Reply.


Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bacharier reports receiving grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute AsthmaNet; and personal fees from Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Schering, Cephalon, DBV Technologies, Teva, Boehringer Ingelheim, AstraZeneca, WebMD/Medscape, Sanofi, and Vectura. Dr Guilbert reports receiving personal fees from the American Board of Pediatrics, Teva, GlaxoSmithKline, Regeneron Pharmaceuticals, andMerck; and grants from Teva, GlaxoSmithKline, Centers for Disease Control and Prevention, Department of Health and Human Services, NIH, University of Wisconsin-MadisonMedical and Education Research Committee, Abbott Laboratories, Array Biopharma, Mylan, Forest Research Institute, Hoffman-LaRoche, MedImmune, KaloBios Pharmaceuticals, Vertex Pharmaceuticals, Roxane Laboratories, CompleWare Corporation, Cystic Fibrosis Foundation Therapeutics, Roche/Genetech, and royalties from UpToDate. Dr Martinez reports receiving grants fromNational Institute of Environmental Health Sciences and personal fees from Abbott.

DOI: 10.1001/jama.2016.1118

Cite this paper

@article{Callaghan2016LeprosyAA, title={Leprosy as a Cause of Distal Symmetric Polyneuropathy--Reply.}, author={Brian C. Callaghan and R. Stephen Price and Eva L. Feldman}, journal={JAMA}, year={2016}, volume={315 19}, pages={2123-4} }